Skip to main content

Table 3 Five-year relative survival (RSR) and relative excess risk (RER) during the first five years after diagnosis of NHL, NSW Australia 1990-2004.

From: Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia

 

5-yr RSR (%)

RER*

95% CI†

P-value

Period of survival

   

<0.0001

   1990-1994

53.3

1.00

  

   1995-1999

55.9

0.89

(0.84-0.94)

 

   2000-2004

62.1

0.74

(0.69-0.78)

 

Sex

   

<0.0001

   Males

57.5

1.00

  

   Females

57.5

0.86

(0.82-0.91)

 

Age at diagnosis (years)

   

<0.0001

   15-44

66.6

1.00

  

   45-59

70.3

1.03

(0.94-1.13)

 

   60-74

58.3

1.56

(1.44-1.70)

 

   75-89

39.5

2.95

(2.71-3.20)

 

NHL grouping

   

<0.0001

   Agressive B-cell

45.2

1.00

  

   Indolent B-cell

73.1

0.30

(0.28-0.32)

 

   Other NHL

61.0

0.92

(0.86-0.97)

 

   NHL NOS

46.6

0.62

(0.54-0.71)

 
  1. * Adjusted for all covariates shown in the table using a Poisson regression model
  2. † CI - confidence interval